Drugs as materials: valuing physical form in drug discovery
- 1 November 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 3 (11), 926-934
- https://doi.org/10.1038/nrd1550
Abstract
Traditionally, potency and selectivity (and to some extent metabolism) have been the key parameters to consider in the process of discovering new drug candidates. Recently, heads of research and CEOs have been learning a new reality: drugs can move around the body and act at the molecular level, but the chemical and material properties of their physical form need to be identified and optimized for in vivo performance, reliable manufacture and the protection of intellectual property. This review discusses the challenge of pharmaceutical materials discovery, and suggests strategies for addressing the characterization and evaluation of physico-chemical and material properties in the drug discovery and development process.Keywords
This publication has 13 references indexed in Scilit:
- High-throughput crystallization: polymorphs, salts, co-crystals and solvates of phan-naceutical solidsAdvanced Drug Delivery Reviews, 2004
- Crystal structures of drugs: advances in determination, prediction and engineeringNature Reviews Drug Discovery, 2004
- Salt Selection and Simultaneous Polymorphism Assessment via High-Throughput Crystallization: The Case of SertralineOrganic Process Research & Development, 2003
- High-Throughput Surveys of Crystal Form Diversity of Highly Polymorphic Pharmaceutical CompoundsCrystal Growth & Design, 2003
- Crystal Engineering of Novel Cocrystals of a Triazole Drug with 1,4-Dicarboxylic AcidsJournal of the American Chemical Society, 2003
- Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallizationProceedings of the National Academy of Sciences of the United States of America, 2003
- An automated workstation for forced degradation of active pharmaceutical ingredientsJournal of Pharmaceutical Sciences, 2002
- Ritonavir: An Extraordinary Example of Conformational PolymorphismPharmaceutical Research, 2001
- Role of pharmacokinetics in the discovery and development of indinavirAdvanced Drug Delivery Reviews, 1999
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997